“…The bacterial genera Clostridium sp., Eubacterium sp., Clostridium leptum , C. paraputrificum , C. perfringens , and C. clostridiiforme exhibited nitroreductase and azoreductase activities in the human GI tract [ 101 – 104 ]. Misal and Gawai have classified azoreductase superfamily into five different groups, depending upon their preference for nicotinamide and flavin: (1) flavin-containing NADPH-dependent azoreductase [ 105 , 106 ], (2) flavin-containing NAD(P)H-dependent azoreductase [ 107 – 110 ], (3) flavin-containing NADH-dependent azoreductase [ 111 , 112 ], (4) flavin-containing NAD(P)H-dependent quinine oxidoreductases [ 113 , 114 ], and (5) flavin-free NAD(P)H-dependent azoreductase [ 115 – 118 ]. Azo drugs like olsalazine, asacol, pentasa, balsalazide, azulfi dine, and salazopyrin for the treatment of ulcerative colitis and inflammatory bowel disease (IBD) [ 119 , 120 ] are pro‐drugs, having 5‐aminosalicylate (5‐ASA), a non-steroidal anti-inflammatory molecule, and an inert carrier are linked with an azo bond, in order to avoid their rapid adsorption [ 121 , 122 ].…”